View PDF Version - RePub - Erasmus Universiteit Rotterdam

Stratton MR, Darling J, Lantos PL, Cooper CS, Reeves BR (1989) Cytogenetic abnonnalities in human
ependymomas. Int J Cancer 44:579-581.
Stiirzbecher HW, Maimets T, Chumakov P, Brain R, Addison C, Simanis V, Rudge K et al. (1990) p53
interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene 5:795-
801.
Su KL, Vogelstein B, Kinzler KW (1993) Association of the APe tumor suppressor protein with catenins.
Science 262: 1734-1737.
Su LK, Jolmson KA, Smith KI, Hill DE, Vogelstein B, Kinzler KW (1993) Association between wild type and
mutant APe gene products. Cancer Res 53:2728-2731.
Sume~i J, Uzvolgyi E, Klein G (1990) Expression of the Rb gene under the control of MuLV -LTR suppresses
tumorigenicity of WERI-Rb-27 retinoblastoma cells in inmmnodefective mice. Cell Growth Diff 1:247-250.
Takahashi M. Ritz J, Cooper GM (1985) Activation of a novel human transforming gene, ret, by DNA
rearrangement. Cell 42:581-588.
Takahashi R, Hashimoto T, Xu HJ, Hu SX, Matsui T, Miki T. Bigo-Marshall H et al. (1991) The
retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Nail
Acad Sci USA 88:5257-526 t.
T'Ang A, Varley JM, Chakraborty S, Murphree AL, Fung YKT (1988) Structural rearrangement of the
retinoblastoma gene in human breast carcinoma. Science 241:1797-1800.
Tanaka N, Nishisho I, Yamamoto M, Miya A, Shin E, Karakawa K, Fujita S et al. (1992) Loss of
heterozygosity on the long arm of chromosome 22 in pheochromocytoma. Genes Chrom Cancer 5:399-403.
Thalmeier K, Synovzik H, Mertz R, Winnacker EL, Lipp M (1989) Nuclear factor E2F mediates basic
transcription and trans-activation by EI of the human Myc promotor. Genes Dev 3:527-536.
Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science
260:816-819.
Toguchida J, Yamaguchi T, Dayton SH et al. (1992) Prevalence and spectrum of germline mutations ofthe p53
gene among patients with sarcomas. N Engl J Med 326:1301-1308.
Ton ce, Huff V, Call KM, Cohn S, Stong Le, Housman DE, Saunders OF (1991) Smallest region of overlap
in Wilms tumor deletions uniquely implicates an IIp13 zinc finger as the disease locus. GenonUcs 10:293-297.
Trofaller JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R et al. (1993) A novel
moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatOSIs 2 tumor suppressor. Cell 72:791-800.
van Tuinen P, Dobyns WB, Rich DC, Summers KM, Robinson TJ, Nakamura Y, Ledbeller DH (1988)
Molecular detection of microscopic ans submicroscopic deletions associated with Miiler-Dieker syndrome. Am
J HUnl Genet 43:587-596.
Tycko B (1994) Genomic imprinting: Mechanism and role in human pathology. Am J Path 144:431-443.
Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M et al. (1992) Frequent loss of
heterozygosity at the Dee locus in gastric cancer. Cancer Res 52:3099-3102.
Upton ML, Weller RO (1985) The morphology of cerebrospinal fluid drainage pathways in human araclmoid
granulations. J Neurosurg 63:867-875.
Vagner-Capodano AM, Grisoli F, Gambarelli D, Sedan R, Pellet W, De Victor B (1993) Correlation between
cytogenetic and histopathological findings in 75 human meningiomas. Neurosurg 32:892-900.
Varley JM, Armour J, Swallow JE, Jeffreys AJ, Ponder BA, T'Ang A, Fung YK et al. (1989) The
retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene
4:725-729.
Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, WolffRK, Culver M el al. (1990) Deletions and
a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192.
Vogel stein B, Fearon ER, Hamilton SR, Scott EK, Preisinger AC, Leppart M, Nakamura Y et al. (1988)
Genetic alterations during colorectal tumor development. N Eng J Moo 319:525-532.
51